In this issue:
- Variations in mammographic surveillance in regional NZ
- Treatment decision regret amongst women with early breast cancer
- Patient-reported outcomes for low-risk ductal carcinoma in situ
- Axillary surgery in breast cancer
- Reproductive factors associated with mammographic breast density
- OS with pembrolizumab in early-stage triple-negative breast cancer
- Trastuzumab deruxtecan after endocrine therapy in metastatic breast cancer
- Trastuzumab emtansine in residual HER2-positive breast cancer
- Neoadjuvant nivolumab in early ER-positive breast cancer
- Cannabidiol for scan-related anxiety in advanced breast cancer
Please login below to download this issue (PDF)